https://finance.yahoo.com/news/pfizer-why-its-fy2024-downgrade-has-wall-street-wary-195841679.html
0
0
12/14/23 at 7:58pm
Organization
Yahoo Entertainment
Author
Anjalee Khemlani
Pfizer is facing more doubt and scrutiny as it lacks a blockbuster to fill its coffers after the pandemic boom subsides.
Create an account
or login to join the discussion